{"filing":{"accession_number":"0002077096-26-000203","cik":"0000816956","ticker":"CNMD","company_name":"CONMED Corp","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"ea0295016-8k_conmed.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/816956/000207709626000203/ea0295016-8k_conmed.htm"},"events":[{"id":11623,"run_id":10208,"accession_number":"0002077096-26-000203","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"John E. Gallagher has been appointed as Executive Vice President and Chief Financial Officer of CONMED Corporation, effective July 15, 2026, with a compensation package including a base salary of $650,000 and equity grants totaling approximately $3.8 million.","company_name":"CONMED Corp","ticker":"CNMD","filing_date":"2026-06-17","submitted_at":null,"items":[{"id":8265,"accession_number":"0002077096-26-000203","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"John E. Gallagher has been appointed as Executive Vice President and Chief Financial Officer of CONMED Corporation, effective July 15, 2026. The disclosure details his appointment to this principal financial officer role, including his compensation package (base salary of $650,000, equity grants totaling approximately $3.8 million, and severance provisions). This is a material executive appointment affecting the company's senior leadership and financial reporting structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:51:10.606686+00:00","company_name":"","ticker":null,"filing_date":""},{"id":8266,"accession_number":"0002077096-26-000203","item_number":"7.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.35,"reasoning":"Item 7.01 is a catch-all disclosure provision for events not covered by other Items. The filing references \"matters described above\" and a press release (Exhibit 99.1), but the actual substance of those matters is not provided in this excerpt. Without visibility into what the press release announces, the materiality and specific event type cannot be determined. This appears to be a boilerplate Regulation FD disclosure wrapper rather than substantive disclosure itself.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:51:10.606686+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8265,"accession_number":"0002077096-26-000203","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"John E. Gallagher has been appointed as Executive Vice President and Chief Financial Officer of CONMED Corporation, effective July 15, 2026. The disclosure details his appointment to this principal financial officer role, including his compensation package (base salary of $650,000, equity grants totaling approximately $3.8 million, and severance provisions). This is a material executive appointment affecting the company's senior leadership and financial reporting structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:51:10.606686+00:00","company_name":"CONMED Corp","ticker":"CNMD","filing_date":"2026-06-17"},{"id":8266,"accession_number":"0002077096-26-000203","item_number":"7.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.35,"reasoning":"Item 7.01 is a catch-all disclosure provision for events not covered by other Items. The filing references \"matters described above\" and a press release (Exhibit 99.1), but the actual substance of those matters is not provided in this excerpt. Without visibility into what the press release announces, the materiality and specific event type cannot be determined. This appears to be a boilerplate Regulation FD disclosure wrapper rather than substantive disclosure itself.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:51:10.606686+00:00","company_name":"CONMED Corp","ticker":"CNMD","filing_date":"2026-06-17"}]}